Polyglucose solutions in CAPD

Peritoneal Dialysis International

Volumn 17, Issue SUPPL. 2, 1997, Pages

  Wilkie, Martin E ^a   Brown, Colin B ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Glucose polymer; Icodextrin; Ultrafiltration

Indexed keywords

CREATININE; GLUCOSE; GLUCOSE POLYMER; ICODEXTRIN; MALTOSE; PERITONEAL DIALYSIS FLUID; UNCLASSIFIED DRUG; UREA;

CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CONFERENCE PAPER; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; HEALTH CARE COST; HUMAN; KIDNEY FAILURE; MEMBRANE TRANSPORT; PRIORITY JOURNAL; SURVIVAL; ULTRAFILTRATION;

EID: 0030779507     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089701702s09     Document Type: Conference Paper

References (24)

1. Harty J and Gokal R. Does CAPD provide adequate dialysis? Nephrol Dial Transplant 1995; 10:1115-7.
2. Report on the management of renal failure in Europe, XXIV, 1993. Nephrol Dial Transplant 1995; 10 (Suppl 5):11-12.
3. Churchill DM, Thorpe KE, Nolph KD, Oreopoulos DG, Page D, Keshaviah PR, for the Canada/USA Peritoneal Dialysis Study Group. CAPD patient and technique survival are worse with increased membrane permeability (Abstract). Perit Dial Int 1996; 16 (Suppl 2):S21.
4. Heimburger O, Waniewski J, Werynski A, Tranaeus A, Lindholm B. Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int 1990; 38:495-506.
5. Monquil MCJ, Imholz ALT, Struijk DG, Krediet RT. Does impaired transcellular water transport contribute to net ultrafiltration failure during CAPD?Perit Dial Int 1995; 15:42-8.
6. Mistry CD, Gokal R. Icodextrin in peritoneal dialysis: early development and clinical use.Perit Dial Int 1994;14 (Suppl 2):S13-21.
7. Mistry CD and Gokal R. Optimal use of glucose polymer (icodextrin) in peritoneal dialysis.Perit Dial Int 1996;16 (Suppl 1):S104-8.
8. Herbert SC, Schafer JA, Andreoli TE. Principles of membrane transport. In: Brenner BM, Rector FC Jr, eds.The Kidney (2nd ed). Philadelphia: W.B. Saunders, 1981; 116-143.
9. Ho-Dac-Pannekeet MM, Schouten N, Langendijk MJ, et al. Peritoneal transport characteristics with glucose polymer based dialysate. Kidney Int 1996; 50:979-86.
10. Mistry CD, Gokal R, Peers EM, and the MIDAS study group. A randomized multicenter clinical trial comparing isosmolar Icodextrin with hyperosmolar glucose solutions in CAPD. Kidney Int 1994; 46:496-503.
11. Krediet RT, Brown CB, Imholz ALT, Koomen GCM. Protein clearance and icodextrin.Perit Dial Int 1994; 14 (Suppl 2):S39-44.
12. Peers EM, Scrimgeour AC, Haycox AR. Cost-containment in CAPD patients withultrafiltration failure. Clin Drug Invest 1995; 10 (1):53-8.
13. Wilkie ME, Plant MJ, Edwards J, Brown CB. Icodextrin 7.5% dialysate solution (glucose polymer) in patients with ultrafiltration failure: extension of CAPD technique survival. Perit Dial Int 1997; 17(1):84-7.
14. Di Paolo N, Sacchi G. Peritoneal vascular changes in continuous ambulatory peritoneal dialysis. An in vivo model for the study of diabetic microangiopathy. Perit Dial Int 1989; 9:41-5.
15. Nakayama M, Kubo H, Ogawa A, et al. Immunohistochemical detection of advanced glycation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int 1997; 51:182-6.
16. Honda K, Nitta K, Horita S, Yumura W, Nihei H. Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure. Nephron 1996; 72:171-6.
17. Ho-dac-Pannekeet MM, Struijk DG, Krediet RT. Glucose free dialysate in patients with ultrafiltration failure: improvement of transcellular water transport. Presented to Renal Association UK, March 27-29, 1996.
18. Twardowski KZJ, Nolph KD, Khanna R. Peritoneal Equilibriation Test. Perit Dial Bull 1987; 4:139-141.
19. Alsop RM. History, chemical, and pharmaceutical development of icodextrin. Peri Dial Int 1994; 14 (Suppl 2):S5-12.
20. Lam-Po-Tang MKL, Bending MK, Kwan JTC. Icodextrin hypersensitivity in a CAPD patient.Perit Dial Int 1997; 17(1):82-4.
21. Krediet RT, Struijk DG, Boeschoten EW, et al. The time course of peritoneal transport kinetics in continuous ambulatory peritoneal patients who develop sclerosing peritonitis. Am J Kid Dis 1989; 13 (4):299-307.
22. Davies D. Kinetics of Icodextrin.Perit Dial Int 1994; 14 (Suppl 2): S45-50.
23. Krediet RT. Fluid absorption in the peritoneum - it is less simple than you thought.Nephrol Dial Transplant 1994; 9 (4):341-3.
24. Lamb EJ, Worral J, Buhler R, Harwwod S, Cattell WR, Dawnay AB. Effects of diabetes and peritonitis on the peritoneal equilibriation test. Kidney Int 1995; 47:1760-7.